{"name":"Nycomed","slug":"nycomed","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Fibrinogen human (TachoSil)","genericName":"Fibrinogen human (TachoSil)","slug":"fibrinogen-human-tachosil","indication":"Hemostasis in surgical procedures","status":"phase_3"},{"name":"Matrifen","genericName":"Matrifen","slug":"matrifen","indication":"Other","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fentanyl (Matrifen)","genericName":"Fentanyl (Matrifen)","slug":"fentanyl-matrifen","indication":"Chronic pain management in opioid-tolerant patients","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Nasal fentanyl","genericName":"Nasal fentanyl","slug":"nasal-fentanyl","indication":"Acute pain management","status":"phase_3"}]}],"pipeline":[{"name":"Fentanyl (Matrifen)","genericName":"Fentanyl (Matrifen)","slug":"fentanyl-matrifen","phase":"phase_3","mechanism":"Fentanyl is a synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system to produce analgesia and sedation.","indications":["Chronic pain management in opioid-tolerant patients","Cancer pain"],"catalyst":""},{"name":"Fibrinogen human (TachoSil)","genericName":"Fibrinogen human (TachoSil)","slug":"fibrinogen-human-tachosil","phase":"phase_3","mechanism":"TachoSil is a fibrin sealant that provides hemostasis by combining human fibrinogen and thrombin to form a stable fibrin clot at the surgical site.","indications":["Hemostasis in surgical procedures","Tissue adhesion in cardiac, vascular, and general surgery"],"catalyst":""},{"name":"Matrifen","genericName":"Matrifen","slug":"matrifen","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nasal fentanyl","genericName":"Nasal fentanyl","slug":"nasal-fentanyl","phase":"phase_3","mechanism":"Nasal fentanyl is a potent opioid agonist that binds to mu-opioid receptors in the central nervous system to provide rapid pain relief through intranasal delivery.","indications":["Acute pain management","Breakthrough pain in opioid-tolerant patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE5oMHNNZVFJNG9JMUpZeVBxUzJkVXZlR29lSl9xeUJjQ1FrMzc4NE90OEl3empOeFJudU02M2V2Zy1XeDFidGh4eU1HUkFUMGgzRUpnVkFmNF9nb25hYnhpYTdYcms?oc=5","date":"2021-09-19","type":"pipeline","source":"Science | AAAS","summary":"Hunting Ghosts - Science | AAAS","headline":"Hunting Ghosts - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOZVllV2djZzNzNFNNT3prakw1bjF3Y01zb0RZcjZKYkNKM3lCcTREeFNKc2tMWVRYUGlSeWhMWUwwUHAxa0xMZmdEV0RHYkxsZ3htS1JLbU83bjA5WkoxdUNiT1MzY0dIc0ZxSUZRamV5N3N0dzVqclJnT0xCQmdjcEx0Yk82MXlQSTExNXZiVUxyUGlIS2FMR1ZmV2s?oc=5","date":"2021-07-04","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Teva and Sun Pharma settle battle over generic Protonix - Generics and Biosimilars Initiative","headline":"Teva and Sun Pharma settle battle over generic Protonix","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNSC1PNnlDV2hZMFRHOUk2dkZQVDQ0aUxMWjBDdUNjUFc5RHlVMkxKYnp6TkgzbjFlNFpBZ1IySFU4ZXFMemYtb21EVFh6T2J1cHlFYkhTd1Zwd0Z3bVhYejNQNmVUbXk5VjlicTducEVWX1JYTEZ1NC0xRll5SWQtag?oc=5","date":"2018-08-11","type":"pipeline","source":"Bain & Company","summary":"Global Healthcare Private Equity Report 2012 - Bain & Company","headline":"Global Healthcare Private Equity Report 2012 - Bain & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNXzMyVmFfem9uclo0M21tYU1UNnBqZzdzWHF2anJEU1VWWXZ2V2hsLWc2dDg3bmQtbHRUUjF1bHpoYnU3ek9VdTg3TVRsZDdNckJQRkJ2dEtyczB2RkNjazRnRjF2MFoyRXNYem1aWTdGNmlNNmhwWXgyc3lvTmFOYkU3cHVNNnpfQzh3cHVaTm9PZE5PY2FkX1Jhdk1PQVFNSGF1NG1qWVY4QQ?oc=5","date":"2018-08-01","type":"pipeline","source":"healthcare-in-europe.com","summary":"Two more cancer drug-candidates for Bayer Schering Pharma AG - healthcare-in-europe.com","headline":"Two more cancer drug-candidates for Bayer Schering Pharma AG - healthcare-in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPUHNVOEtFNC1XRmY1Rl9OR2JEMUdLb0VmRWRYcnJpUnNnQldwcDhkU1VyRVdCSzVYeU44REE1bWFFX3kwTVhReTU2X0ZtNnFkNFF2R0JxaU9NVmFja2dQTERwRGh5VTVLaV9nZGJHczUtbi1DdmJOaWRZRklqNzNpRjR3Mnk4Y0Zo?oc=5","date":"2018-04-27","type":"deal","source":"Pharmaceutical Technology","summary":"Takeda chases after its largest deal yet - Pharmaceutical Technology","headline":"Takeda chases after its largest deal yet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQWE9KTDNUWGFXUzlMV21WWk5nWTdZblVrVDM5ZWtkNTlrSlZxM0VWQUhqdnBqd0ZaVkpPSVBhZXhnZVJ1d1gtSW9BajVqSVpUZmxUckVoSGRJRDRVcXdVQ2UzUXFoV3NScjYwenFvSGZGR2NONjZzN0tIaWtUS0JEMVUzcHRxVDZLbXoyTUhEOGFTVmZhcVJfNFlua0NoOGc?oc=5","date":"2013-06-26","type":"patent","source":"IPWatchdog.com","summary":"Largest Patent Settlement Scores $2.15 Billion for Pfizer, Takeda - IPWatchdog.com","headline":"Largest Patent Settlement Scores $2.15 Billion for Pfizer, Takeda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOcHBxOFhVTUdFcW1RQ0Q0OTdJX2FNal9raWRnV2lOc3RXZml2YkFBZjFBTzl4LUxfUjVJSUFqYzR3RldkTTRqQ1RPczJZVDEzRXRfUl9SeDZrQzRJa3BTT1ZUekZpb3BuQ29EMXdCNDdaMVo1b2RkaE1TZU5DLUxlRHV5SHhoNExRbGIxUzhtdWRlcjZfbWc?oc=5","date":"2013-02-20","type":"pipeline","source":"PMLiVE","summary":"Former Nycomed CEO Hakan Bjorklund to chair Lundbeck - PMLiVE","headline":"Former Nycomed CEO Hakan Bjorklund to chair Lundbeck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQZXZSMjJjaVFMTU1MUnFISlFQZXBKMnlWaEI4elJiRExCSm1McUlGUFVMM3dXRzBocjVON29qeXpKd2ZJbHpzSHNZZ3hCTWFaYlFEdzd3cnZLa3Y1RmhqMkdLbnNTM3pDMGtTVW1EQUpRQk9QZE9rZ2dVR2t6dHZSaF9pa1VEQzFVOHZqUFZfZWVtb0c2S094aEdVSzFfNngzdHJLdlhOYlMzSEtpZ0E?oc=5","date":"2012-10-03","type":"deal","source":"Forbes","summary":"Nycomed Deal Shows How Small PE Firms Can Reap Billions - Forbes","headline":"Nycomed Deal Shows How Small PE Firms Can Reap Billions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNa1ZHX0drZktvTFdZN3RZeWlRNE1Gbndqekc5VVN1RW9hd1R2ellkal9GV3k5cFd3NUI2RVgtZGZlanVNNjNjaG5RZk9IR21NbDU1dGkxeE9vSEx5TmNOSWg4RVZFMUZoMkgtLXN1RVRhMmgyTGJHNW84S1EyRTRoYmlqUW1ENENGUFpGbkNUWUtZVG1qUnpvZ2Nn?oc=5","date":"2011-10-03","type":"pipeline","source":"Pharmafile","summary":"Takeda completes Nycomed acquisition, installs new chief executive - Pharmafile","headline":"Takeda completes Nycomed acquisition, installs new chief executive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOQldOZllXVzlYeVVXSkFVZGliS0JzcE95RnJkSnVkXzNaS1d3UXlxSzdEbWVPdXJCbWZIaTVCbWM4M09SVG1YZ2dVRDUyX1laWTVRb2U0SGJXcUNacF92WFZZZVZNdFZxc3Z6T09DdzRWQTF2ZG9MczdKclJzbE9rai1YUzFfWVd2YjVCODdleWFfU3hl?oc=5","date":"2010-07-19","type":"patent","source":"Fierce Pharma","summary":"Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid - Fierce Pharma","headline":"Nycomed's U.S. Patent for Protonix(R) (pantoprazole) Valid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1WNndpXzY3a3RDQ3J6QXlxal9sdXhiLTRaQng2bEdJS0tMNVdUM1NoVDFVbkRoRjMxS0ZSV0ZPWnJyUnVId3N4Zl9YbHBzamFTYVB3LUUxamxrLWpkTlpZWE9YeGRWa3dQRjZTcjRSc3FaVDZiTUpZ0gF8QVVfeXFMTy1ib1h6Yks4TlZfS0Yxc00zRUlmVUhOVlBIaktKUEppSzl2SmFYZ0RZZ1B0a2l0UUY1X2ozbk5ZTjVHdWhJZVFKYWhubThLbWlpTG1IMXJBb0hSMXVvTEhNbG9rSFItTDRaSFEtMUxMOHo4S1owVjd3bFdUcQ?oc=5","date":"2008-11-13","type":"pipeline","source":"CNBC","summary":"Pharma And The Financial Crisis - CNBC","headline":"Pharma And The Financial Crisis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNcWpRdnVPb3dSLWktR2duZUNEYXJjOE9zWTlhbFFGbEpFUFo4cFNCV3pIZmRfUWRWbU1HYlpKREUwVGZYSDhNYy1sR1NaX2lBM2FUQm9wLVV5aDRGRlJGTTJsRVJSWXJfd0FXZkpaMlFoREJmTDkyaTBWUk1lWEZLbjRET1Rva1RIc3gtWGJjWWVnU0V3dVh2U1dpOW5OVDNaQW0xWmlzQnNjV1ZZWEJUaEQwRDd2RUdZaGlrQ3FBaw?oc=5","date":"2006-09-25","type":"pipeline","source":"Technology Networks","summary":"Altana Announces Sale of Pharmaceuticals Business to Nycomed - Technology Networks","headline":"Altana Announces Sale of Pharmaceuticals Business to Nycomed","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}